AI assistant
NEOGEN CORP — Director's Dealing 2022
Dec 23, 2022
32081_dirs_2022-12-23_bc9063eb-6491-4300-94d7-55ccf7214979.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEOGEN CORP (NEOG)
CIK: 0000711377
Period of Report: 2022-12-13
Reporting Person: Rocklin Amy M (Chief Legal & Reg. Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Restricted Stock Units | $40.85 | 2026-10-12 | Common Stock (1176) | Direct | |
| Restricted Stock Units | $28.4 | 2027-04-25 | Common Stock (2817) | Direct | |
| Restricted Stock Units | $13.28 | 2025-10-06 | Common Stock (27108) | Direct | |
| Common Stock (Right to Buy) | $40.85 | 2026-11-12 | Common Stock (9269) | Direct | |
| Common Stock (Right to Buy) | $28.4 | 2027-05-25 | Common Stock (14724) | Direct | |
| Common Stock (Right to Buy) | $13.28 | 2025-10-06 | Common Stock (120537) | Direct |
Footnotes
F1: The RSUs were granted on 10/12/2021, have 5 year lives, and vest in equal annual installments on each of the five anniversary dates of the grant
F2: The RSUs were granted on 4/25/2022, have five year lives, and vest in equal annual installments on each of the first five anniversary dates of the grant
F3: The RSUs were granted on 10/6/2022, have three year lives and vest in equal annual installments on the first three anniversary dates of the grant
F4: Options were granted on 10/12/2021,have five year lives and vest in equal annual installments on each of the first five anniversary dates of the grant
F5: Options were granted on 4/25/2022, have five year lives, and vest in equal annual installment on each of the first five anniversary dates of the grant
F6: Options were granted on 10/6/2022, have three year lives, and vest in equal annual installments on each of the first three anniversary dates of the grant